U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07246473) titled 'Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage' on Sept. 23.

Brief Summary: Intracerebral hemorrhage (ICH) is one of the stroke subtypes with the highest global rates of disability and mortality, accounting for 15%-20% of all strokes. Currently, there is a lack of evidence-based interventions for ICH, with treatment primarily relying on supportive care. There is an urgent clinical need to explore new strategies and technologies. The investigators hypothesize that for ICH patients, best medical treatment combined with a non-invasive ultrasonic scalpel (ultrasound Doppler flow analyzer) may be superior t...